|
Company data displayed is for sample purposes only and may not reflect the most current information available on Emerging Markets Information Service (EMIS).
Transcu Group Limited
Main Activities: Pharmaceutical and Medicine Manufacturing
 |
Please check the full coverage of information what EMIS can offer you. | SEE SAMPLE |
Company Information |
|
Full name Transcu Group Limited Headquarters 50 Raffles Place, Singapore Land Tower, #45-01/02; Singapore; Singapore; 048623 |
Status: Listed Legal Form: Public Limited Company Operational Status: Operational ISIN CODE : SG1B05007508 Financial Auditors: KPMG (1993) Incorporation Date: July 24, 1968 Total Employees: 126 Tel: (65) 6734 0028 |
|
Company Description |
| The principal activities of the Company are those of rental of retail space. It also acts as a holding company and provides management services to its subsidiaries. The principal activities of the subsidiaries are those of cinema operators, film distributors, rental of office and retail space, operation and management of concession stands. The Group principal activities are those of rental of retail space. It also acts as a holding company and provides management services to its subsidiaries. The | ||
|
||
Company Analysis |
| According to the Consolidated - Non-Audited financial statement for the first two cumulated quarters of 2013, total net operating revenues decreased with -25.89%, from USD 5,280 thousands to USD 3,913 thousands. Operating result increased from USD -8,110 thousands to USD -6,062 thousands which means 25.25% change. The results of the period increased 27.57% reaching USD -4,749 thousands at the end of the period against USD -6,557 thousands last year. Return on equity (Net income/Total equity) went from -61.85% to -344.88%, the Return On Asset (Net income / Total Asset) went from -27.98% to -23.91% and the Net Profit Margin (Net Income/Net Sales) went from -124.19% to -121.36% when compared to the same period of last year. The Debt to Equity Ratio (Total Liabilities/Equity) was 1487.87% compared to 116.25% of last year. Finally, the Current Ratio (Current Assets/Current Liabilities) went from 0.50 to 0.27 when compared to the previous year. |
Key Executives |
|
|||||
|
|||||
|
|||||
|
|||||
|
|||||
|
|||||
Companies with Similar Main Activities |
FULL COMPANY PROFILE
|
| SELECT CURRENCY |
| Figures in: USD | EUR |
|
2013 Q3C (cons) |
2013 Q2C (cons) |
|
 | ||
| Non-Audited | Non-Audited | |
| ||
| WVB Company Financials | WVB Company Financials | |
| ||
| Unit | Thousands | Thousands |
| ||
Balance Sheet
| ||
Total Assets |
34,555 |
19,863 |
| ||
Current Assets |
5,130 |
4,151 |
| ||
Total Liabilities |
18,577 |
20,488 |
| ||
Shareholders Equity |
14,965 |
-1,377 |
| ||
Current Liabilities |
18,981 |
15,502 |
| ||
| * All the accounts are in USD. | ||
Income Statement
| ||
Total Operating Revenue |
5,116 |
3,913 |
| ||
Operational Profit (Loss) |
-9,859 |
-6,062 |
| ||
Net Profit (Loss) |
-10,567 |
-4,749 |
| ||
| * All the accounts are in USD. | ||
Ratios
| Profitability Ratios | ||
| ||
Return on Assets (ROA) |
-30.58% |
-23.91% |
| ||
Annualised Return on Assets (ROA) |
-40.77% |
-47.82% |
| ||
Return on Equity (ROE) |
-66.13% |
759.84% |
| ||
Annualised Return on Equity (ROE) |
-88.17% |
1,519.68% |
| ||
Return on Sales (ROS) |
-206.55% |
-165.24% |
| ||
Return on Capital |
-66.13% |
-105.98% |
| ||
Gross Profit Margin |
99.8% |
74.04% |
| ||
Operating Profit Margin |
-91.79% |
-132.67% |
| Efficiency Ratios | ||
| ||
Accounts Receivable Turnover |
3.30x |
4.04x |
| ||
Inventory Turnover |
0.01x |
0.56x |
| ||
Current asset turnover |
1.00x |
0.69x |
| ||
Fixed-asset turnover |
0.17x |
0.18x |
| ||
Asset Turnover |
0.15x |
0.14x |
| Valuation figures and ratios | ||
| ||
Earning Before Interests and Taxes (EBIT) |
-9,829 |
-6,143 |
| ||
EBITDA |
-8,499 |
-5,231 |
| ||
Enterprise value |
23,420 |
117,884 |
| ||
Enterprise Value / EBITDA |
-2.76 |
-22.54 |
| ||
Bookvalue (BV) |
34,555 |
14,602 |
| ||
Net Cash |
-18,469 |
-15,489 |
| Liquidity Ratios | ||
| ||
Current Ratio |
27.03% |
26.78% |
| ||
Quick ratio |
20.8% |
18.17% |
| ||
Doom's day ratio |
2.7% |
0.08% |
| Leverage Ratios | ||
| ||
Leverage ratio |
216.27% |
-3,178.08% |
| ||
Interest Coverage Ratio |
-11,842.17% |
-11,813.46% |
| ||
Debt to equity |
116.27% |
-3,278.08% |
| ||
Debt to total assets |
53.76% |
103.15% |
| ||
Long Term Debt to Capital |
-0.29% |
3.98% |
| ||
Debt / Enterprise Value |
0% |
4.46% |
| Market ratios | ||
| ||
Market Capitalization/EBITDA |
-2.94 |
-21.68 |
| ||
Price/Book Ratio |
0 |
18.98 |
| ||
Market Cap / Net cash |
-1.35 |
-7.32 |
| Trend Ratios | ||
| ||
Revenue Trend |
88.99% |
80.17% |
| ||
Net Income Trend |
106.11% |
72.43% |
| ||
Operating Income Trend |
84.41% |
75.75% |
| ||
 |